A detailed history of Vestal Point Capital, LP transactions in Monte Rosa Therapeutics, Inc. stock. As of the latest transaction made, Vestal Point Capital, LP holds 930,000 shares of GLUE stock, worth $7.77 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
930,000
Previous 890,000 4.49%
Holding current value
$7.77 Million
Previous $3.33 Billion 48.08%
% of portfolio
0.37%
Previous 0.25%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.59 - $6.97 $143,600 - $278,800
40,000 Added 4.49%
930,000 $4.93 Billion
Q2 2024

Aug 14, 2024

BUY
$3.38 - $7.86 $3.01 Million - $7 Million
890,000 New
890,000 $3.33 Billion

Others Institutions Holding GLUE

About Monte Rosa Therapeutics, Inc.


  • Ticker GLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,713,900
  • Market Cap $391M
  • Description
  • Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...
More about GLUE
Track This Portfolio

Track Vestal Point Capital, LP Portfolio

Follow Vestal Point Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestal Point Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Vestal Point Capital, LP with notifications on news.